Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.

Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Abstract Text:

    tao luTao Lu,liping tianLiping Tian,yulong hanYulong Han,michael vogelbaumMichael Vogelbaum,george r starkGeorge R Stark,

    Some tumor cell lines secrete high concentrations of TGFbeta or IL-1. Similarly high concentrations of each of these cytokines cross-activate the other pathway: TGFbeta activates NFkappaB, and IL-1beta activates Smads. The IL-1 signaling components IRAK, MyD88, TRAF6, and TAK1 are all required for cross-activation of NFkappaB by TGFbeta. Knockdown experiments revealed that both TGFbeta receptor subunits are required for IL-1beta to activate Smads, and the IL-1 receptor is required for TGFbeta to activate NFkappaB. Coimmunoprecipitations showed that either TGFbeta or IL-1beta stimulate ligand-dependent association of all three receptor subunits. Furthermore, cross-talk between the TGFbeta and IL-1 signaling pathways leads to dose-dependent cross-control of gene expression. These interactions provide new insight into biological responses to IL-1 and TGFbeta in the proximity of tumors that secrete high concentrations of these factors and probably also at sites of inflammation, where the local concentrations of these cytokines are likely to be high.

    Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Publishing Authors By Initials

    t luT Lu,l tianL Tian,y hanY Han,m vogelbaumM Vogelbaum,gr starkGR Stark,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

    PUBMED ID PMID:

    MEDLINE DATE:

    Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Proceedings of the National Academy of Sciences of

    VOLUME: 104

    Page Numbers: 4365-70

    Journal Abbreviation: Proc. Natl. Acad. Sci. U.S.A.

    ISSN: 0027-8424

    DAY: 5

    MONTH: 03

    YEAR: 2007

    Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7505876

    Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Information

    Substance Name: MAP Kinase Kinase Kinases

    Registry Number: EC 2.7.1.37

    Grant and Affiliation Information for Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways.

    AFFILIATION: Department of Molecular Genetics, Lerner Research Institute, and Brain Tumor Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: P01 CA 62220

    ACRONYM: CA

    MEDLINETA: Proc Natl Acad Sci U S A

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News